An Epidemiological Cohort Study of Acute Coronary Syndromes in The Greek Population. The PHAETHON Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02420808

Acronym

PHAETHON

Enrollment

800

Registered

2015-04-20

Start date

2012-03-31

Completion date

2014-01-31

Last updated

2017-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

CAD, STEMI, non STEMI, Unstable angina, Greece

Brief summary

A nationwide registry of patients with acute coronary disease to evaluate epidemiological patient characteristics, medical management, implementation of invasive strategy, patient outcome and impact on quality of life in Greece.

Detailed description

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

25 Years to No maximum

Healthy volunteers

Inclusion criteria

* Informed Consent * \> 25 years * Admission in hospital within 24 hours from beginning of symptoms of transfer from antother hospital within 24 hours from beginning of symptoms. * Acute Coronary Syndrom

Exclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
Evaluation of patients with Acute Coronary Syndromes.	6 months	Assessment of the epidemiological characteristics of patients who were hospitalized with a diagnosis of ACS. Evaluation of the therapeutic strategy and its outcome.

Secondary

Measure	Time frame	Description
Description of the methods of patients' evacuation.	Baseline	Description of the methods of patients' evacuation from the scene of the incident to the receiving hospital where was processed the treatment for ACS.
Estimation of the interval until the arrival in the hospital.	Baseline	Estimation of the duration from the onset of pain until the arrival in the receiving hospital at various locations.
Estimation of the percentage of patients.	Baseline	Estimation of the percentage of patients who were hospitalized with STEMI, NSTEMI and unstable angina.
Description of the administered medication.	Baseline - 6 months	Description of the pharmaceutical treatment administered during hospitalization and monitoring period.
Evaluation of the male patients with erectile dysfunction.	Baseline - 6 months	Estimation of the percentage of the male patients with erectile dysfuction based to a predesigned questionnaire and investigation of the possible association with the treatment's outcome.
Evaluation of the blood test analysis during hospitalization.	Baseline	Evaluation of hematological, biochemical parameters and myocardial necrosis markers during hospitalization.

Countries

Greece

Outcome results